| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 37,845 | 40,632 | ||
| Short-term investments | 16,936 | 31,136 | ||
| Accounts receivable, net | 17 | 0 | ||
| Prepaid expenses and other current assets | 7,799 | 5,988 | ||
| Total current assets | 62,597 | 77,756 | ||
| Property and equipment, net | 3,935 | 4,051 | ||
| Right-of-use lease assets, net | 737 | 825 | ||
| Intangible assets, net | 47 | 48 | ||
| Other assets | 45 | 45 | ||
| Total assets | 67,361 | 82,725 | ||
| Accounts payable | 1,994 | 2,294 | ||
| Accrued liabilities | 8,932 | 7,933 | ||
| Contract liabilities | 165 | 164 | ||
| Current lease liabilities | 336 | 350 | ||
| Total current liabilities | 11,427 | 10,741 | ||
| Non-current lease liabilities | 445 | 520 | ||
| Other non-current liabilities | 118 | 122 | ||
| Total liabilities | 11,990 | 11,383 | ||
| Ordinary shares, 0.000174 par value 400,000 shares authorized 55,786 shares issued and outstanding at september 30, 2025 and 55,349 shares issued and outstanding at december 31, 2024 | 10 | 10 | ||
| Additional paid-in capital | 442,544 | 441,413 | ||
| Accumulated other comprehensive loss | -1,277 | -1,375 | ||
| Treasury shares | 180 | 180 | ||
| Accumulated deficit | -385,726 | -368,526 | ||
| Total shareholders' equity | 55,371 | 71,342 | ||
| Total liabilities and shareholders' equity | 67,361 | 82,725 | ||
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)